Quatera 700 vs. Centurion - Trial NCT06225362
Access comprehensive clinical trial information for NCT06225362 through Pure Global AI's free database. This phase not specified trial is sponsored by Carolina Eyecare Physicians, LLC and is currently Recruiting. The study focuses on Cataract. Target enrollment is 40 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Carolina Eyecare Physicians, LLC
Timeline & Enrollment
N/A
Jan 10, 2024
Aug 30, 2024
Primary Outcome
Central corneal thickness,Lens removal time
Summary
Phacoemulsification is the most common treatment for cataract surgery in the developed
 countries and over the years it gained importance due to several factors: small incision,
 surgery performed under topical anesthesia - which reduce injection-related complications -
 short recovery time, low post operatory induced astigmatism, and low incidence of surgical
 complications, when compared to the conventional surgeries. The study evaluates 2 different
 phacoemulsification devices in patients undergoing routine cataract surgery in both eyes.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06225362
Device Trial